NCT07297940

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 in Healthy Subjects at Fasting State

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DA-1229_01	single dose administration (DA-1229 one tablet once a day)
DRUG	DA-1229_01-R	single dose administration (DA-1229\_01-R one tablet once a day)

Timeline

• Start date: 2025-12-14
• Primary completion: 2026-01-31
• Completion: 2026-01-31
• First posted: 2025-12-22
• Last updated: 2026-03-31

Locations

1 site across 1 country: South Korea